CA2551578A1 - Complexe de lignanes derive des graines de lin, servant a traiter l'atherosclerose hypercholesterolemique - Google Patents

Complexe de lignanes derive des graines de lin, servant a traiter l'atherosclerose hypercholesterolemique Download PDF

Info

Publication number
CA2551578A1
CA2551578A1 CA002551578A CA2551578A CA2551578A1 CA 2551578 A1 CA2551578 A1 CA 2551578A1 CA 002551578 A CA002551578 A CA 002551578A CA 2551578 A CA2551578 A CA 2551578A CA 2551578 A1 CA2551578 A1 CA 2551578A1
Authority
CA
Canada
Prior art keywords
composition
mammal
lignan complex
weight
lignan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002551578A
Other languages
English (en)
Inventor
Kailash Prasad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Saskatchewan
Original Assignee
University of Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Saskatchewan filed Critical University of Saskatchewan
Priority to CA002551578A priority Critical patent/CA2551578A1/fr
Publication of CA2551578A1 publication Critical patent/CA2551578A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002551578A 2006-07-07 2006-07-07 Complexe de lignanes derive des graines de lin, servant a traiter l'atherosclerose hypercholesterolemique Abandoned CA2551578A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002551578A CA2551578A1 (fr) 2006-07-07 2006-07-07 Complexe de lignanes derive des graines de lin, servant a traiter l'atherosclerose hypercholesterolemique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002551578A CA2551578A1 (fr) 2006-07-07 2006-07-07 Complexe de lignanes derive des graines de lin, servant a traiter l'atherosclerose hypercholesterolemique

Publications (1)

Publication Number Publication Date
CA2551578A1 true CA2551578A1 (fr) 2008-01-07

Family

ID=38920785

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002551578A Abandoned CA2551578A1 (fr) 2006-07-07 2006-07-07 Complexe de lignanes derive des graines de lin, servant a traiter l'atherosclerose hypercholesterolemique

Country Status (1)

Country Link
CA (1) CA2551578A1 (fr)

Similar Documents

Publication Publication Date Title
JP5103179B2 (ja) スタチンおよびオメガ−３脂肪酸を含む組成物
CN100475208C (zh) 高脂血症治疗药剂
JP3340135B2 (ja) ３―ヒドロキシ―３―メチルグルタリルＣｏＡ（ＨＭＧ―ＣｏＡ）レダクターゼ阻害剤としての柑橘類果皮抽出物
US6541522B2 (en) Methods of using compositions containing hypotriglyceridemically active stilbenoids
US20080009449A1 (en) Lignan complex derived from flax seed used for treatment of hypercholesterolemic atherosclerosis
EA010373B1 (ru) Фармацевтические композиции, содержащие высшие первичные спирты и эзетимиб, и способ их получения
WO2015136441A1 (fr) Phytocomplexes issus de citrus bergamia
JP5722632B2 (ja) エネルギー利用疾病の治療
Najafian et al. Citral as a potential antihyperlipidemic medicine in diabetes: a study on streptozotocin-induced diabetic rats
Ullah et al. Assessment of antidiabetic potential and phytochemical profiling of Viscum album, a traditional antidiabetic plant
JP2022512465A (ja) 脂質異常症の抑制を目的としたベルベリスとレスベラトロルの混合物の使用
Akinpelu et al. Evaluation of anti-hyperlipidemic potential of ethanolic leaf extract of Clerodendrum volubile P. Beauv
KR101577002B1 (ko) 울금과 용암해수를 이용한 항콜레스테롤 또는 간기능 개선용 조성물과 기능성 식품
JP5091859B2 (ja) アシル−ＣｏＡ：コレステロールアシルトランスフェラーゼ阻害用組成物
US20120121732A1 (en) Composition for Use in the Prevention and Treatment of Cardiovascular Diseases
US20020058708A1 (en) Compositions containing hypotriglyceridemically active stilbenoids
US20170304336A1 (en) Combination
CA2551578A1 (fr) Complexe de lignanes derive des graines de lin, servant a traiter l'atherosclerose hypercholesterolemique
EP0739629B1 (fr) Nouvelles associations comprenant du (-)hydroxycitrate et présentant notamment de nouvelles activités thérapeutiques
Winarsi et al. Hypocholesterolemic and attenuated oxidized-LDL of epinephrine-induced atherosclerosis rats using cardamom rhizome ethanolic extract: study of functional-food components.
KR20190058394A (ko) 옻나무 목질부 추출물을 포함하는 어류의 항균, 항기생충, 항바이러스 및 항산화 조성물
RU2699802C1 (ru) Средство на основе L-рамнопиранозил-6-O-метил-D-галактуронана, обладающее гиполипидемической активностью
JP2009275026A (ja) 膵臓リパーゼ活性阻害作用を有する組成物
EA009918B1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ВЫСШИЕ ПЕРВИЧНЫЕ АЛИФАТИЧЕСКИЕ СПИРТЫ И ИНГИБИТОР ГМГ-КоА-РЕДУКТАЗЫ, И СПОСОБ ИХ ПОЛУЧЕНИЯ
KR20140144433A (ko) 파리유충 에탄올 추출물을 유효성분으로 포함하는 고지혈증 예방 또는 치료용 약제학적 조성물

Legal Events

Date Code Title Description
FZDE Dead